The YOU-Fish Study: Fish and Omega 3 Supplementation in Young Adults
YOU-Fish
The YOU-Fish Study: Exploring the Effects of Fish Consumption and Omega 3 Supplementation on the Vascular Health of Young Adults
1 other identifier
interventional
40
1 country
1
Brief Summary
Cardiovascular disease (CVD) is one of the major causes of mortality, however, it is estimated that approximately 75% of all cases are preventable. Previous evidence has shown higher blood concentrations of n-3 polyunsaturated fatty acids (PUFAs) are associated with a lower risk of cardiovascular disease owing to their ability to lower inflammation. The omega-3 index (O3I) is a commonly used marker of n-3 PUFA status, which refers to the percentage of n-3 long chain PUFAs (with respect to total fatty acids) in red blood cell membranes, with an O3I of \>8% associated with the lowest risk of CVD. Concerningly it's estimated that most of the population have an O3I ranging from 4-5%. Fish is a rich source of polyunsaturated fatty acids (PUFA) and has been shown to be one of the main predictors of a higher O3I. Current guidelines recommend the consumption of 2 portions of fish per week; however, current UK and Irish intakes are well below the current recommendations, particularly amongst young people. Additionally, professional bodies have noted that a daily omega-3 supplement, providing approximately 500mg EPA + DHA per day, is beneficial in increasing omeag-3 intakes amongst those who may exclude dietary sources such as fish. The regular consumption of fish or omega 3 supplement use could help to increase the O3I, however, it remains unknown as to whether the guidance surrounding these methods are effective in reaching the recommended target of 8%. Early interventions such as increasing the O3I (throughfish and/or supplements) into a lower risk category may be an effective intervention in the prevention of CVD. This human intervention study will investigate the effects of omega 3 supplements and fish on the O3I and vascular health of young adults. It is hypothesised that increasing fish consumption or taking omega 3 supplements will increase the O3I and improve the vascular health of young adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedFirst Posted
Study publicly available on registry
December 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedDecember 11, 2024
October 1, 2024
7 months
November 15, 2024
December 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Omega 3 index measured as percentage
Assessed via Gas-Chromatography mass spectrometry
Change at 8 weeks from baseline
Secondary Outcomes (1)
Polyunsaturated fatty acid status
Time frame: change at 8 weeks from baseline
Other Outcomes (3)
Inflammatory status
Change at 8 weeks from baseline
Lipid Profile
Change at 8 weeks from baseline
Microbiota
Change at 8 wees from baseline
Study Arms (4)
Fish and Placebo
EXPERIMENTALParticipants will receive 2 portions of fish (280g)
No fish SUPPLEMENT
EXPERIMENTALDaily 1g omega-3 supplement
No fish PLACEBO
EXPERIMENTALPlacebo
2 fish portion
EXPERIMENTALOmega 3 supplement
Interventions
Experimental - 2 portions of fish (280g) per week and placebo supplement (corn oil)
Experimental - Control lunch (no fish) and omega 3 supplement
Eligibility Criteria
You may qualify if:
- Omega 3 index \<6% Healthy males or females.
- Aged 18-30 years old.
- Low consumers of fish (\<2 portions/month).
- Willing to 2 portions (280 grams) of fish per week.
- Not consuming fish oil supplements.
- Not consuming protein supplements.
- Within a BMI of 18-30kg/m2
- Not allergic to seafood
You may not qualify if:
- Omega 3 index \>6%
- Regularly consume fish.
- Are allergic to seafood.
- Are taking fish oil supplements (for example fish oil, cod oil, krill oil, GLA or evening primrose) or are taking protein supplements (for example whey protein).
- Are pregnant/lactating.
- Have existing health conditions such as Diabetes Mellitus and known hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NICHE, School of Biomedical Sciences, Biomedical Sciences Research, Coleraine Campus, University of Ulster
Coleraine, Co Londonderry, BT52 1SA, United Kingdom
Related Publications (1)
McMullan JE, Kumar RA, Yeates AJ, Allsopp PJ, Mulhern MS, van Wijngaarden E, Strain JJ, McSorley EM. Influence of Fish Consumption and omega-3 Supplementation on the omega-3 Index of Young Adults: A 2 x 2 Factorial Randomized Controlled Trial (YouFish Study). J Nutr. 2025 Dec;155(12):4345-4355. doi: 10.1016/j.tjnut.2025.10.010. Epub 2025 Oct 11.
PMID: 41082976DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emeir McSorley, PhD
Ulster University, Cromore Road, Coleraine, Co. Londonderry, BT521SA.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2024
First Posted
December 11, 2024
Study Start
December 1, 2024
Primary Completion
June 30, 2025
Study Completion
July 31, 2025
Last Updated
December 11, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share